Please assess the completion status of the following clinical trial:

Trial Title: Use of Closed-loop Anesthesia in Pediatric Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* class ASA I, II or III~* general anesthesia scheduled to last more than one hour~* intraoperative hemorrhage planned to be less than 15% of the blood volume~Exclusion Criteria:~* Combined general and regional anesthesia,~* Patients with a pacemaker or scheduled for a cardiac or brain surgical procedure,~* History of a neurological or a psychiatric disorder, or central brain lesion,~* Patients receiving a psychotropic treatment or a a morphine agonist-antagonist,~* Allergy to latex, propofol, remifentanil, morphine, muscle relaxant, or to a component,~* Hypersensibility to remifentanil or to a derivate of fentanyl,~* Scheduled postoperative ventilation or sedation.

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 16 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): closed-loop administration of propofol and remifentanil using bispectral index as the controller
- 2 (Type: ACTIVE_COMPARATOR): manual administration of propofol and remifentanil according to bispectral index values

Based on this trial design, predict the completion outcome and termination type (if applicable).